Literature DB >> 24900108

An unusual case of anaphylaxis after fluorine-18-labeled fluorodeoxyglucose injection.

Dong Yun Lee1, Jong Jin Lee1, Hyouk-Soo Kwon2, Woo Yeon Moon1, So-Young Jin1, Sang Ju Lee1, Seung Jun Oh1, Jin Sook Ryu1.   

Abstract

[(18)F]FDG (fluorine-18 fluoro-2-deoxy-D-glucose) positron emission tomography (PET) is used worldwide for oncologic and neurologic applications. To date, the potential harm caused by [(18)F]FDG has focused on its radiation exposure effects rather than on its pharmacological effects. While an allergic response in the form of a skin manifestation has been reported after exposure to [(18)F]FDG, this report describes the first case of hypotension following exposure to this tracer. Here, the development of anaphylaxis after [(18)F]FDG injection is described.

Entities:  

Keywords:  Allergic; Anaphylaxis; FDG

Year:  2013        PMID: 24900108      PMCID: PMC4035188          DOI: 10.1007/s13139-013-0202-z

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  16 in total

1.  Severe systemic reaction to (99m)Tc-methylene diphosphonate: a case report.

Authors:  Kottekkattu K Balan; Arabinda K Choudhary; Anupama Balan; Gordon Wishart
Journal:  J Nucl Med Technol       Date:  2003-06

Review 2.  Anaphylaxis: recognition and management.

Authors:  James J Arnold; Pamela M Williams
Journal:  Am Fam Physician       Date:  2011-11-15       Impact factor: 3.292

Review 3.  Anaphylaxis: diagnosis and management.

Authors:  Simon G A Brown; Raymond J Mullins; Michael S Gold
Journal:  Med J Aust       Date:  2006-09-04       Impact factor: 7.738

Review 4.  Epidemiology of anaphylaxis.

Authors:  Phil Lieberman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2008-08

5.  Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.

Authors:  E B Silberstein
Journal:  J Nucl Med       Date:  1998-12       Impact factor: 10.057

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Anaphylactic reaction to Tc-99m sestamibi (Cardiolite) during pharmacologic myocardial perfusion imaging.

Authors:  Bilal Mujtaba; Michael Adenaike; Vamsee Yaganti; Najda Mujtaba; Diwakar Jain
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

8.  Epimerization study on [18f]FDG produced by an alkaline hydrolysis on solid support under stringent conditions.

Authors:  C Mosdzianowsk; C Lemaire; F Simoens; J Aerts; J L Morelle; A Luxen
Journal:  Appl Radiat Isot       Date:  2002-06       Impact factor: 1.513

9.  Anaphylaxis to oral furosemide.

Authors:  J Domínguez-Ortega; J C Martínez-Alonso; C Domínguez-Ortega; M J Fuentes; A Frades; T Fernández-Colino
Journal:  Allergol Immunopathol (Madr)       Date:  2003 Nov-Dec       Impact factor: 1.667

10.  Allergy to technetium-labelled nanocolloidal albumin for sentinel node identification.

Authors:  Dennis W Chicken; Reza Mansouri; Peter J Ell; Mohammed R S Keshtgar
Journal:  Ann R Coll Surg Engl       Date:  2007-03       Impact factor: 1.891

View more
  1 in total

1.  Associations between cancer-related information seeking and receiving PET imaging for routine cancer surveillance--an analysis of longitudinal survey data.

Authors:  Andy S L Tan; Laura Gibson; Hanna M Zafar; Stacy W Gray; Robert C Hornik; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-18       Impact factor: 4.254

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.